In the latest win for Regeneron Pharmaceuticals and Sanofi’s Dupixent (dupilumab), the partners announced positive results from a Phase III trial of the blockbuster in kids ages one to 11 years with eosinophilic esophagitis (EoE).
Beset by clinical holds and the termination of its former company head, CytoDyn Inc. has tapped Cyrus Arman as its new president and he is expected to take over the reins of the company as chief executive officer and be added to the board of directors within six months.
The European Medicines Agency on Thursday identified severe allergic reactions as potential side effects of Novavax Inc.’s COVID-19 vaccine.
Neil Matheson, Chairman, Atlantis Health discusses the most significant changes he’s witnessed over the past few decades.
Canada has approved Moderna Inc.’s COVID-19 vaccine for children aged 6 months and older, according to information posted on the government’s website.
“Authorizing an additional COVID-19 vaccine expands the available vaccine options for the prevention of COVID-19, including the most severe outcomes that can occur such as hospitalization and death,” said FDA Commissioner Robert M. Califf, M.D.
China-based drug developer BeiGene said on Thursday the U.S. Food and Drug Administration (FDA) has delayed a decision on its cancer drug as COVID-19 curbs in the country prevented the regulator from conducting inspections.
ReutersEU seeks to upgrade safety rules for blood, tissue, cell donations BRUSSELS, July 14 (Reuters) – The European Commission proposed on Thursday updated rules on blood, tissue and cells to […]
With technologies rapidly diversifying and cell and gene therapies (C>s) gaining recognition among patient groups as treatments with immense curative potential, there are clear opportunities for marketers to differentiate from existing, often palliative, approaches to care. Ben Beckley, president at Evoke Mind+Matter, an Inizio company, explores why it’s more important than ever to stand out in the market and looks at some of the opportunities on the horizon for C> developers.
The Biden administration said on Wednesday that refusing to fill prescriptions for drugs that could be used to terminate a pregnancy could violate federal law, regardless of various state bans on the procedure.
